From mapping genomes to new software for monitoring trials, new technologies are revolutionizing the every-day business of clinical research. The emphasis is on efficiency and accuracy: innovators are looking for ways to minimize errors in diagnostics and trial management, while maintaining patient health as the highest priority. This week we profile two technological advancements in clinical laboratory tools that achieve that delicate balance. The first tool upgrades diagnostics from manual to molecular, while the second provides project teams with a full-service trial management system that is rapidly closing the gap on error and oversight during clinical trials. Molecular Diagnostics:.. READ MORE »
Watery eyes, scratchy throat, angry rashes. From pesky annoyance to life threatening reaction: how many of us suffer from allergies? Health Canada says that non-food allergies have become chronic in people over the age of twelve. Over 65 million Americans have some sort of allergy, and in Europe over 87 million people struggle to control allergen sensitivities. Controlling allergies is a big business, and because typical treatments only ease symptoms rather than eliminating the root cause, allergies continue to torment their victims. On the quest for a definitive cure, researchers are on the lookout for new data and permanent solutions… READ MORE »
Since the first successful sequencing of the human genome in 2003, technology has evolved to make DNA mapping faster and more cost-effective than ever. In the health care sector, genomics has paved the way for customized therapies for patients suffering from a range of illnesses including cancer, HIV/AIDS, epilepsy, neurological conditions, and cardiovascular disease. A more complete understanding of a patient’s genetic map means more effectively targeted drugs and a more efficient health care system. Students currently enrolled in pharmaceutical courses will emerge into a marketplace where customizable drug therapies are a booming business. The power to examine the genomes.. READ MORE »
Health Canada recently issued a warning regarding the dangers of psychoactive drugs, in particular synthetic blends that replicate the effects of controlled substances. The development and distribution of synthetics falls within a legal grey area, and has sparked new debate about how the government should regulate this new “market.” Without the safety measures associated with pharmaceutical quality control, synthetic psychoactive drugs like Acetyl Fentanyl are developed and sold with little knowledge regarding their safety or effects on users. Psychoactive drugs impact brain functioning, and cause changes in mood and behavior; they are usually prescribed to treat physical and psychological disorders… READ MORE »
This month, after years of discussion, Canada signed a Canada-EU Free Trade deal. The Comprehensive Economic Trade Agreement (CETA) is testing the waters for dropping import tariffs on everything from cars to food in trade between Canada and the European Union’s member states. Part of the agreement includes pharmaceutical imports, which is, understandably, a game changer for the industry. At this stage in negotiations, this includes establishing working groups to resolve differences in Canadian and European standards, not necessarily topics such as pharmaceutical quality assurance, which is already more or less in sync, but to help facilitate negotiations of the.. READ MORE »
It was once believed that a university degree was all Canadians needed to secure relatively stable and desirable employment. But these days, students are graduating at the top of their class only to find themselves at the end of an unemployment line. A rocky economy and the changing landscape of post-secondary education have made choosing a program of study more confusing than ever. In June of 2013, CBC News reported that unemployment rates for recent grads were at 14.5% and rising. Conditions are no better across the border, where the Wall Street Journal reported that last year 284,000 American college.. READ MORE »
Last year in October, the province of BC defunded the Therapeutics Initiative program, an independent institution to monitor the effects of prescription pharmaceutical drugs. TI is also attached to the University of British Columbia’s Department of Family Practice, and had been working in this capacity since 1994. Defunding from the province did not kill the program. Instead, UBC picked up the shortfall, but TI garnered itself international attention as they campaigned for recognition, nationally and internationally, earning a mention in the prestigious British Medical Journal, as well as an open letter from doctors and research scientists from around the world,.. READ MORE »
This week, we’re taking a look at some of the promising discoveries that have appeared over the last few months. They all share something in common: they all have roots in our ongoing efforts to understand the human genetic code and the biological processes surrounding it, part of a trend that’s opening up a whole range of new cures and treatments. Pharmaceutical discoveries and possible new treatments Messenger RNA (mRNA) normally serves an important role in copying DNA, as part of its transmission. Clinical research-oriented company, CureVac has partnered with pharmaceutical giant Janssen to build on existing, promising research. The.. READ MORE »
Since the Nobel Prize was awarded to Banting and Macleod in 1923 for their discovery of Insulin, Canada has held a place as one of the top countries for pharmaceutical research in the world. Canadian scientists are still being credited with breakthrough discoveries every year, and there is an explicit need for young talent to enter the industry. It is recognized that historically, young researchers are statistically more likely to conduct breakthrough research. Universities and corporate labs know this, and many commit themselves to finding fresh talent. CIHR, the Canadian Institute of Health Research specifically targets young scientists, offering numerous.. READ MORE »
As a student of pharmaceutical or life sciences (or anyone interested in how science is bettering our world), you will inevitably learn about the latest High Performance Liquid Chromatography (HPLC) techniques and how they fit into different industries. At this point, HPLC is an established technique dating back to the early twentieth century, but over the decades, the process has been refined and simplified. It has evolved from a multi-unit process to a standardized procedure with a single piece of laboratory equipment. HPLC works differently that traditional liquid chromatography because it uses a man-made high-pressure process instead of gravity to.. READ MORE »
Contact us directly or provide your information for a call back.
885 Sheppard Avenue West
Toronto, Ontario
M3H 2T4, Canada
Mon-Fri 8:30am – 5:00pm
Sat – by appointment only
2960 Drew Road, Unit 140
Mississauga, Ontario
L4T 0A5, Canada
Telephone: 416-502-2277
Toll Free: 1-855-502-2288
Email: info@aaps.ca
Contact us directly or provide your information for a call back.
AAPS College graduates thrive with leading employers in health, science, and technology, showing how our programs translate into real careers and success.
